- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about GSK
Recent news which mentions GSK
Why Are NanoViricides Shares Gaining Today
July 11, 2023
From Benzinga
From Benzinga
GSK's RSV Vaccine Scores Approval In UK For Older Adults
July 10, 2023
From Benzinga
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
July 07, 2023
From Benzinga
Analyst Creates Bullish Pitch For WAVE Life Sciences, Says It Is 'Leader To Clinic In RNA Editing'
July 05, 2023
From Benzinga
Teva's Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit
July 05, 2023
From Benzinga
Moderna Initiates Regulatory Application Process Seeking Approval For Its RSV Vaccine In Older Adults
July 05, 2023
From Benzinga
Haleon Contemplates Sale of Non-Core Businesses, Including Nicotinell Brand: A Strategy Shift Towards Core Products
July 05, 2023
From Benzinga
First US Trial Over Zantac's Alleged Cancer-Causing Properties Set For November In California
July 03, 2023
From Benzinga
Better Artificial Intelligence Stock: GSK or Eli Lilly?
June 28, 2023
From Motley Fool
From Benzinga
Second Most Prevalent Bacterial Sexually Transmitted Infection: GSK's Gonorrhea Vaccine Secures FDA Track
June 27, 2023
Tickers
GSK
From Benzinga
Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics
June 26, 2023
From Benzinga
Why Shares of CureVac Jumped This Week
June 23, 2023
From Motley Fool
Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 23, 2023
From Benzinga
2 Stocks Defying Friday's Market Downturn
June 23, 2023
From Motley Fool
From Benzinga
GSK Confidentially Settles First Zantac-Associated Cancer Lawsuit Due For US Trial Next Month
June 23, 2023
From Benzinga
The U.K. stock market has turned into a wasteland as pension funds recoil. Why U.S. funds may pull back too
June 23, 2023
From MarketWatch
From Benzinga
U.S. stock futures under pressure on fears aggressive global central banks could drive recession
June 23, 2023
From MarketWatch
Virgin Galactic shares tumble, while Trupanian and GSK climb and other stocks on the move
June 23, 2023
From MarketWatch
From Benzinga
From Benzinga
From InvestorPlace
From Benzinga
GSK's Recently Approved Vaccine Offers Long-Term Protection Against RSV in Older Adults, New Data Reveals
June 21, 2023
Tickers
GSK
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.